Staging heart failure with preserved pumping function
Part of Heart & circulation clinical trials.
This study is testing better ways to understand and manage heart failure where the heart pumps normally but still doesn't work as well as it should. It looks at people with symptoms like shortness of breath and fatigue, using blood tests and heart imaging to check eligibility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have heart failure symptoms that make daily activities a bit harder.
- Your heart's pumping strength is normal (ejection fraction above 50%) on an echo.
- You have either a high NT-proBNP blood level or a past hospital stay for heart failure.
- You must have certain changes in your heart's structure or function, seen on an echo.
- If you take water pills, your dose has been stable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the heart muscle works in people with a type of heart failure where the heart pumps normally but doesn't fill properly. It aims to understand the cause better, which could lead to new treatments.
This study is for people with a type of heart failure called HFpEF, where the heart pumps normally but doesn't relax well. It aims to better understand heart failure through advanced testing, and it includes people who are newly diagnosed or have had a recent hospitalization.
This Phase 2 study tests how matching heart “filling pressure” and heart muscle “energy use” may improve understanding or treatment of HFpEF, a type of heart failure with preserved pumping strength. You may be asked to have heart scans/tests and follow a study plan if your symptoms and test results fit.
This study looks at different types of heart failure with preserved ejection fraction (a form of heart failure where the heart pumps normally but doesn't fill properly). Researchers will use past medical records and possibly a special exercise test to better understand these types and how to treat them.
This trial tests if using a combination of biomarkers can help personalize treatment for people with a specific type of heart failure called HFpEF (or heart failure with preserved ejection fraction). It aims to find better treatments based on your individual test results.
This study looks at people with heart failure who still have a normal pumping ability (HFpEF). Researchers want to find what factors predict a worse outcome, so they can better understand and treat this condition.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.